# Vasopressin for Septic Shock Pragmatic Trial

> **NCT06217562** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Intermountain Health Care, Inc.** · enrollment: 2050 (estimated)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Vasopressin
- **OTHER:** Recommendation to use a lower initiation threshold for vasopressin
- **OTHER:** Recommendation to use a higher initiation threshold for vasopressin

## Key facts

- **NCT ID:** NCT06217562
- **Lead sponsor:** Intermountain Health Care, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-02-01
- **Primary completion:** 2026-07
- **Final completion:** 2027-12
- **Target enrollment:** 2050 (ESTIMATED)
- **Last updated:** 2025-10-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06217562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06217562, "Vasopressin for Septic Shock Pragmatic Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06217562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*